The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau
- 13 February 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (11), 2487-2494
- https://doi.org/10.1016/j.vaccine.2020.01.096
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-BissauThe Journal of Infectious Diseases, 2017
- The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-BissauBMC Pediatrics, 2016
- Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic reviewBMJ, 2016
- A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital AdmissionsThe Journal of Infectious Diseases, 2014
- A small jab – a big effect: nonspecific immunomodulation by vaccinesTrends in Immunology, 2013
- Testing the hypothesis that diphtheria–tetanus–pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countriesBMJ Open, 2012
- Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trialBMJ, 2010
- Evaluation of the optimal recall period for disease symptoms in home-based morbidity surveillance in rural and urban KenyaInternational Journal of Epidemiology, 2010
- Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairsInternational Journal of Epidemiology, 2004
- High-titer measles vaccination before 9 months of age and increased female mortality: do we have an explanation?Seminars in Pediatric Infectious Diseases, 2003